Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma

References

• Aggarwal BB, Shishodia S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol, 71, 1397–1421.
   PubMed Web of Science ®Google Scholar
• Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I, Mor G. (2009). Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle, 8, 158–166.
   PubMed Web of Science ®Google Scholar
• Appel E, Vallon-Eberhard A, Rabinkov A, Brenner O, Shin I, Sasson K, Shadkchan Y, Osherov N, Jung S, Mirelman D. (2010). Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin. Antimicrob Agents Chemother, 54, 898–906.
   PubMed Web of Science ®Google Scholar
• Apte SM, Fan D, Killion JJ, Fidler IJ. (2004). Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma. Clin Cancer Res, 10, 897–908.
   PubMed Web of Science ®Google Scholar
• Arditti FD, Rabinkov A, Miron T, Reisner Y, Berrebi A, Wilchek M, Mirelman D. (2005). Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Mol Cancer Ther, 4, 325–331.
   PubMed Web of Science ®Google Scholar
• Barnes S, Sfakianos J, Coward L, Kirk M. (1996). Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv Exp Med Biol, 401, 87–100.
   PubMedGoogle Scholar
• Berchuck A, Elbendary A, Havrilesky L, Rodriguez GC, Bast RC Jr. (1994). Pathogenesis of ovarian cancers. J Soc Gynecol Investig, 1, 181–190.
   PubMedGoogle Scholar
• Breidenbach M, Rein DT, Everts M, Glasgow JN, Wang M, Passineau MJ, Alvarez RD, Korokhov N, Curiel DT. (2005). Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy. Gene Ther, 12, 187–193.
   PubMed Web of Science ®Google Scholar
• Campos SM, Ghosh S. (2010). A current review of targeted therapeutics for ovarian cancer. J Oncol, 2010, 149362.
   PubMedGoogle Scholar
• de Vos FY, Bos AM, Gietema JA, Pras E, Van der Zee AG, de Vries EG, Willemse PH. (2004). Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer. Anticancer Res, 24, 345–348.
   PubMed Web of Science ®Google Scholar
• de Vos FY, Nuver J, Willemse PH, van der Zee AG, Messerschmidt J, Burgerhof JG, de Vries EG, Gietema JA. (2004). Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage. Eur J Cancer, 40, 696–700.
   PubMed Web of Science ®Google Scholar
• de Wilde A, Heberden C, Chaumaz G, Bordat C, Lieberherr M. (2006). Signaling networks from Gbeta1 subunit to transcription factors and actin remodeling via a membrane-located ERbeta-related protein in the rapid action of daidzein in osteoblasts. J Cell Physiol, 209, 786–801.
   PubMed Web of Science ®Google Scholar
• Erlanger BF, Borek F, Beiser SM, Lieberman S. (1957). Steroid-protein conjugates. I. Preparation and characterization of conjugates of bovine serum albumin with testosterone and with cortisone. J Biol Chem, 228, 713–727.
   PubMed Web of Science ®Google Scholar
• Fishman DA, Bozorgi K. (2002). The scientific basis of early detection of epithelial ovarian cancer: the National Ovarian Cancer Early Detection Program (NOCEDP). Cancer Treat Res, 107, 3–28.
   PubMedGoogle Scholar
• Hilderbrand SA, Kelly KA, Weissleder R, Tung CH. (2005). Monofunctional near-infrared fluorochromes for imaging applications. Bioconjug Chem, 16, 1275–1281.
   PubMed Web of Science ®Google Scholar
• Hirsch K, Danilenko M, Giat J, Miron T, Rabinkov A, Wilchek M, Mirelman D, Levy J, Sharoni Y. (2000). Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer, 38, 245–254.
   PubMed Web of Science ®Google Scholar
• Huang YH, Zugates GT, Peng W, Holtz D, Dunton C, Green JJ, Hossain N, Chernick MR, Padera RF Jr, Langer R, Anderson DG, Sawicki JA. (2009). Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice. Cancer Res, 69, 6184–6191.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. (2006). Cancer statistics, 2006. CA Cancer J Clin, 56, 106–130.
   PubMed Web of Science ®Google Scholar
• Kohen F, Gayer B, Kulik T, Frydman V, Nevo N, Katzburg S, Limor R, Sharon O, Stern N, Somjen D. (2007). Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine. J Med Chem, 50, 6405–6410.
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252–4263.
   PubMed Web of Science ®Google Scholar
• Lamartiniere CA, Wang J, Smith-Johnson M, Eltoum IE. (2002). Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci, 65, 228–238.
   PubMed Web of Science ®Google Scholar
• Landen CN, Kinch MS, Sood AK. (2005). EphA2 as a target for ovarian cancer therapy. Expert Opin Ther Targets, 9, 1179–1187.
   PubMed Web of Science ®Google Scholar
• Lehtonen JY, Adlercreutz H, Kinnunen PK. (1996). Binding of daidzein to liposomes. Biochim Biophys Acta, 1285, 91–100.
   PubMed Web of Science ®Google Scholar
• Migalovich HS, Kalchenko V, Nevo N, Meir G, Kohen F, Neeman M. (2009). Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media. Cancer Res, 69, 5610–5617.
   PubMed Web of Science ®Google Scholar
• Miron T, Mironchik M, Mirelman D, Wilchek M, Rabinkov A. (2003). Inhibition of tumor growth by a novel approach: in situ allicin generation using targeted alliinase delivery. Mol Cancer Ther, 2, 1295–1301.
   PubMed Web of Science ®Google Scholar
• Miron T, Rabinkov A, Mirelman D, Weiner L, Wilchek M. (1998). A spectrophotometric assay for allicin and alliinase (Alliin lyase) activity: reaction of 2-nitro-5-thiobenzoate with thiosulfinates. Anal Biochem, 265, 317–325.
   PubMed Web of Science ®Google Scholar
• Miron T, Rabinkov A, Mirelman D, Wilchek M, Weiner L. (2000). The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta, 1463, 20–30.
   PubMed Web of Science ®Google Scholar
• Miron T, Shin I, Feigenblat G, Weiner L, Mirelman D, Wilchek M, Rabinkov A. (2002). A spectrophotometric assay for allicin, alliin, and alliinase (alliin lyase) with a chromogenic thiol: reaction of 4-mercaptopyridine with thiosulfinates. Anal Biochem, 307, 76–83.
   PubMed Web of Science ®Google Scholar
• Miron T, SivaRaman H, Rabinkov A, Mirelman D, Wilchek M. (2006). A method for continuous production of allicin using immobilized alliinase. Anal Biochem, 351, 152–154.
   PubMed Web of Science ®Google Scholar
• Miron T, Wilchek M, Sharp A, Nakagawa Y, Naoi M, Nozawa Y, Akao Y. (2008). Allicin inhibits cell growth and induces apoptosis through the mitochondrial pathway in HL60 and U937 cells. J Nutr Biochem, 19, 524–535.
   PubMed Web of Science ®Google Scholar
• Morgan RT, Woods LK, Moore GE, Quinn LA, McGavran L, Gordon SG. (1980). Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma. Int J Cancer, 25, 591–598.
   PubMed Web of Science ®Google Scholar
• Prager-Khoutorsky M, Goncharov I, Rabinkov A, Mirelman D, Geiger B, Bershadsky AD. (2007). Allicin inhibits cell polarization, migration and division via its direct effect on microtubules. Cell Motil Cytoskeleton, 64, 321–337.
   PubMed Web of Science ®Google Scholar
• Rabinkov A, Miron T, Konstantinovski L, Wilchek M, Mirelman D, Weiner L. (1998). The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta, 1379, 233–244.
   PubMed Web of Science ®Google Scholar
• Rabinkov A, Miron T, Mirelman D, Wilchek M, Glozman S, Yavin E, Weiner L. (2000). S-Allylmercaptoglutathione: the reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim Biophys Acta, 1499, 144–153.
   PubMed Web of Science ®Google Scholar
• Rabinkov A, Zhu XZ, Grafi G, Galili G, Mirelman D. (1994). Alliin lyase (Alliinase) from garlic (Allium sativum). Biochemical characterization and cDNA cloning. Appl Biochem Biotechnol, 48, 149–171.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Sutherland RM. (1989). Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours. Br J Cancer, 59, 28–35.
   PubMed Web of Science ®Google Scholar
• Schwartz PE. (2002). Current diagnosis and treatment modalities for ovarian cancer. Cancer Treat Res, 107, 99–118.
   PubMedGoogle Scholar
• Shan K, Lincoff AM, Young JB. (1996). Anthracycline-induced cardiotoxicity. Ann Intern Med, 125, 47–58.
   PubMed Web of Science ®Google Scholar
• Shimon LJ, Rabinkov A, Shin I, Miron T, Mirelman D, Wilchek M, Frolow F. (2007). Two structures of alliinase from Alliium sativum L.: apo form and ternary complex with aminoacrylate reaction intermediate covalently bound to the PLP cofactor. J Mol Biol, 366, 611–625.
   PubMed Web of Science ®Google Scholar
• Somjen D, Katzburg S, Nevo N, Gayer B, Hodge RP, Renevey MD, Kalchenko V, Meshorer A, Stern N, Kohen F. (2008). A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma. J Steroid Biochem Mol Biol, 110, 144–149.
   PubMed Web of Science ®Google Scholar
• Somjen D, Kohen F, Lieberherr M, Gayer B, Schejter E, Katzburg S, Limor R, Sharon O, Knoll E, Posner GH, Kaye AM, Stern N. (2005). Membranal effects of phytoestrogens and carboxy derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin A. J Steroid Biochem Mol Biol, 93, 293–303.
   PubMed Web of Science ®Google Scholar
• Starr AN, Vexler A, Marmor S, Konik D, Ashkenasi-Voghera M, Lev-Ari S, Greif Y, Ben-Yosef R. (2005). Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusion. Oncology, 69, 239–245.
   PubMed Web of Science ®Google Scholar
• Tseng JC, Hurtado A, Yee H, Levin B, Boivin C, Benet M, Blank SV, Pellicer A, Meruelo D. (2004). Using sindbis viral vectors for specific detection and suppression of advanced ovarian cancer in animal models. Cancer Res, 64, 6684–6692.
   PubMed Web of Science ®Google Scholar
• Zeineldin R, Muller CY, Stack MS, Hudson LG. (2010). Targeting the EGF receptor for ovarian cancer therapy. J Oncol, 2010, 414676.
   PubMedGoogle Scholar